Skip to main content
All lobbying filings

NVG, LLC

NVG, LLC filed a Q1 report for ACCENDRA HEALTH INC. on April 20, 2026, reporting $80,000 in lobbying income.

Lobbying for ACCENDRA HEALTH INC. · Global healthcare solutions company.

All filings by NVG, LLC · Everything ACCENDRA HEALTH INC. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to diabetes management and durable medical equipment reimbursement channels. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Budget/Appropriations

Report language for FY2027 Appropriations related to changes in the Competitive Bidding Program.

 Bills named in this filing 3

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem